126 related articles for article (PubMed ID: 8191598)
1. High-dose interstitial brachytherapy for glioblastoma multiforme.
Micheletti E; Baroncelli G; La Face B; Feroldi P; Galelli M; Giunta F
Tumori; 1994 Feb; 80(1):44-9. PubMed ID: 8191598
[TBL] [Abstract][Full Text] [Related]
2. High-dose-rate brachytherapy for poor-prognosis, high-grade glioma: (phase II) preliminary results.
Micheletti E; La Face B; Feroldi P; Galelli M; Buttolo L; Stefini R; Giunta F
Tumori; 1996; 82(4):339-44. PubMed ID: 8890967
[TBL] [Abstract][Full Text] [Related]
3. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
4. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
6. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
9. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
10. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral neutron brachytherapy for hemispheric glioblastoma multiforme. A pilot study.
Chin HW; Maruyama Y; Young B; Markesbery W; Goldstein S; Tibbs P; Beach L
J Neurooncol; 1984; 2(4):341-7. PubMed ID: 6099405
[TBL] [Abstract][Full Text] [Related]
13. [Interstitial boost and altered fractionation as novel approaches to dose escalation in the radiotherapy of glioblastoma multiforme].
Mangel L; Julow J; Major T; Hável J; Lövey J; Viola A; Somogyi A; Németh G
Orv Hetil; 2003 Feb; 144(5):223-9. PubMed ID: 12647551
[TBL] [Abstract][Full Text] [Related]
14. CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas.
Kolotas C; Birn G; Baltas D; Rogge B; Ulrich P; Zamboglou N
Br J Radiol; 1999 Aug; 72(860):805-8. PubMed ID: 10624349
[TBL] [Abstract][Full Text] [Related]
15. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
[TBL] [Abstract][Full Text] [Related]
16. Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme.
Koot RW; Maarouf M; Hulshof MC; Voges J; Treuer H; Koedooder C; Sturm V; Bosch DA
Cancer; 2000 Jun; 88(12):2796-802. PubMed ID: 10870063
[TBL] [Abstract][Full Text] [Related]
17. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
[TBL] [Abstract][Full Text] [Related]
18. Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis.
Stea B; Rossman K; Kittelson J; Shetter A; Hamilton A; Cassady JR
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):591-600. PubMed ID: 7928490
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme.
Sneed PK; Lamborn KR; Larson DA; Prados MD; Malec MK; McDermott MW; Weaver KA; Phillips TL; Wara WM; Gutin PH
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):37-44. PubMed ID: 8641924
[TBL] [Abstract][Full Text] [Related]
20. Treatment options in high-grade brain tumors: brain brachytherapy.
Chin HW; Lefkowitz DM; Eisenberg RL
Radiographics; 1992 Jul; 12(4):721-9. PubMed ID: 1321981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]